Ruptured hepatic metastases of cutaneous melanoma during treatment with vemurafenib: an autopsy case report
Authors:
- Takuto NosakaTakuto Nosaka
- Katsushi HiramatsuKHKatsushi Hiramatsu
- Tomoyuki NemotoTNTomoyuki Nemoto
- Yasushi SaitoYSYasushi Saito
- Yoshihiko OzakiYOYoshihiko Ozaki
- Kazuto TakahashiKTKazuto Takahashi
- Tatsushi NaitoTNTatsushi Naito
- Kazuya OfujiKOKazuya Ofuji
- Hidetaka MatsudaHMHidetaka Matsuda
- Masahiro OhtaniMOMasahiro Ohtani
- Hiroyuki SutoHSHiroyuki Suto
- Yoshiaki ImamuraYIYoshiaki Imamura
Open Access
- 3 September 2015
- journal article
- case report
- Published by Springer Nature in BMC Clinical Pathology
- Vol. 15 (1) , 15
Abstract
The spontaneous rupture of hepatic metastases is rare compared to that of primary hepatic tumors. In addition, vemurafenib, a selective inhibitor of the mutant BRAF protein or gene product, has been reported to be extremely effective in patients with metastatic melanoma who harbor a BRAF V600E mutation. A 44-year-old female had previously undergone surgery for resection of a malignant melanoma in the lower right leg. Four years later, hepatic metastases became apparent, and transcatheter arterial embolization (TAE) was performed. Then she underwent treatment with vemurafenib. The size of the hepatic metastases markedly decreased. Two months later, they enlarged rapidly and ruptured, requiring emergency TAE. However, the patient developed hemorrhagic shock and died of renewed intra-abdominal bleeding on the 26th postoperative day. This is a rare case of ruptured hepatic metastases of malignant melanoma during treatment with vemurafenib. Postmortem examination and immunohistochemical analysis indicated reactivation of the mitogen-activated protein kinase pathway in the metastatic tumor, suggesting secondary resistance to vemurafenib as the possible underlying mechanism.Keywords
This publication has 19 references indexed in Scilit:
- Ruptured Liver Metastasis With Active Hemorrhage Has the Classic Appearance of a Giant Cavernous Hemangioma on 99mTc-Labeled RBC ScintigraphyClinical Nuclear Medicine, 2012
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationNew England Journal of Medicine, 2011
- Inhibition of Mutated, Activated BRAF in Metastatic MelanomaNew England Journal of Medicine, 2010
- Massive bleeding of ruptured metastatic hepatic melanoma treated by transarterial embolizationJapanese Journal of Radiology, 2010
- Mutations of the BRAF gene in human cancerNature, 2002
- Spontaneous hepatic rupture due to metastatic malignant melanoma1991
- Percutaneous Angiographic Embolization for Hepatic Arterial HemorrhageArchives of Surgery, 1985
- Survival after liver resection for secondary tumorsThe American Journal of Surgery, 1978
- Spontaneous rupture of liver tumoursBritish Journal of Surgery, 1976
- Spontaneous Rupture of Hepatocellular CarcinomaBMJ, 1972